1. Home
  2. SMTI vs GF Comparison

SMTI vs GF Comparison

Compare SMTI & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$22.02

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

Logo New Germany Fund Inc. (The)

GF

New Germany Fund Inc. (The)

HOLD

Current Price

$11.93

Market Cap

191.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMTI
GF
Founded
1982
1990
Country
United States
Germany
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
208.2M
191.2M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SMTI
GF
Price
$22.02
$11.93
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$34.00
N/A
AVG Volume (30 Days)
39.4K
58.1K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
0.82%
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$15,586,976.00
N/A
Revenue This Year
$17.31
N/A
Revenue Next Year
$12.48
N/A
P/E Ratio
$426.80
N/A
Revenue Growth
32.47
N/A
52 Week Low
$16.05
$9.98
52 Week High
$35.70
$12.82

Technical Indicators

Market Signals
Indicator
SMTI
GF
Relative Strength Index (RSI) 51.19 55.16
Support Level $20.52 $11.74
Resistance Level $24.17 $12.38
Average True Range (ATR) 1.42 0.35
MACD -0.18 -0.02
Stochastic Oscillator 43.65 64.17

Price Performance

Historical Comparison
SMTI
GF

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

About GF New Germany Fund Inc. (The)

NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investments includes investments in different sectors such as the industrials, information technology, materials, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.

Share on Social Networks: